27-Feb-17 With an economic potential still largely untapped, the Greater Mekong Region should be front and center in the plans of any pharma, medical device or biotech organization looking to expand in Asia. Among the volatile and unpredictable emerging markets throughout Asia, Vietnam and Myanmar have shown strong growth in their economies and appetite for pharma and medical devices. [image: Life Science Leader]

 Insights

20-Feb-17 Raffles Medical Group is ramping up in China and Indochina as strong demand for quality healthcare offer attractive growth opportunities. It is also growing its portfolio of corporate clients with more multinational companies using its medical services outside of Singapore, including Japan, Vietnam and China. It also logged revenue of SGD474 mn, a 15% increase compared with a year ago. [image: Raffles Medical Group / Nikkei Asian Review]

14-Feb-17 Japanese medical device producer Nipro will spend USD300 mn on a new factory in Vietnam, to meet rising domestic and foreign demand. The factory will make catheters and other products for dialysis for sale mainly in Japan and Southeast Asia. Nipro has relied on a Thai subsidiary to produce for these markets but has now decided to increase capacity. [image: Nikkei Asian Review / Nipro]

08-Dec-16 As competition heats up in Singapore between private and public healthcare providers, many are looking at regional expansion for growth opportunities. Across the hospital players in the region, consensus is looking towards emerging markets like Cambodia and Vietnam for expansion. [image: Company, OIR]

31-Oct-16 Quang Ninh Province in Vietnam is extending healthcare services to rural populations by providing telehealth across 24 hospitals and community healthcare centres. Quang Ninh is mountainous, and access to healthcare means long journeys to a central hospital or medical centre. The Polycom video technology allows consultations for patients hundreds of kilometres away, and improved training for doctors in rural areas. [image: Networks Asia]